SCHEMBL23946752

SCHEMBL23946752

c1ccc(-c2nc(-c3cccc4ccc5c6ccccc6ccc5c34)nc(-c3cncc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 5/20 0.36
HSD17B10 Q99714 5/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPK1 P28482 4/20 0.36
TSHR P16473 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TP53 P04637 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 1/20 0.36
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
LMNA P02545 2/20 0.35
RECQL P46063 1/20 0.35
TNF P01375 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23946966 0.94 MAPT (0.39) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL25508989 0.92 TDP1 (0.39) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24472866 0.92 MAPT (0.42) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL24951385 0.92 MAPT (0.42) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL25509115 0.92 CYP1A2 (0.37) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL27326072 0.89 PRKCZ (0.36) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL25465705 0.89 MAPT (0.36) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL25512711 0.89 TNF (0.41) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL25509104 0.89 MAPT (0.37) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL25509106 0.89 MAPT (0.37) MAPTALDH1A1HPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237518-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-07-11 US disclosed
US-20240237518-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-07-11 US disclosed
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-27 US disclosed
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-06-08 US disclosed
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-06-08 US disclosed
WO-2023090836-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-25 WO disclosed
WO-2023085908-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed
WO-2023085878-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed
WO-2023085881-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed
WO-2021210911-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY2, CYBA, AHR MAPT 3026/4885ALDH1A1 484/4885HPGD 3930/4885
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, AHR MAPT 2757/4885ALDH1A1 182/4885HPGD 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.